ipilimumab,int230-6,pembrolizumab
bms,intensity therapeutics,merck
['breast', 'keytruda', 'yervoy', 'int230-6', 'sarcoma', 'intensity therapeutics']
at #asco22 three abstacts were selected for 3 poster and 2 podium discussion session. data in #sarcoma and #breastcancer for int230-6 alone, and in other #cancers combined with keytruda and int230-6 with yervoy were shown.
Intensity Therapeutics is a clinical stage, biotechnology company whose mission is to create safer and more efficacious cancer therapies.